Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Madharry who wrote (65642)	12/8/2020 10:32:24 PM
From: Steve Felix	Read Replies (2) \| Respond to of 78958

Here's my bet. Those not at the meeting to exercise their rights couldn't run fast enough and it cascaded. NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM or the "Company"), a special purpose acquisition company (SPAC) that previously announced an agreement to acquire 180 Life Sciences Corp. ("180 Life Sciences"), today announced that a special meeting (the "Meeting") of the stockholders of KBL Merger Corp. IV (the "Company") was held on November 5, 2020, where all proposals, including the proposal to approve the proposed business combination with 180 Life Sciences, were approved. In connection with the special meeting, stockholders of KBLM holding 816,461 public shares exercised their right to redeem such public shares into a pro rata portion of the Trust Account. As a result, an aggregate of approximately $9,006,492.76 will be removed from the Company's trust account to pay such holders. Following such redemptions, a total of approximately $1,367,364.54 will remain in the trust account.